China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
China NT Pharma Group Co., Ltd. has announced the termination of a significant acquisition, after having already issued shares to consultants for project milestones in drug development and clinical trials. Despite the project’s early termination, lock-up arrangements have been set to protect the company’s interests. Furthermore, the company has engaged consultants for an additional three years to enhance their orthopedic product line, amidst challenges such as changes in regulations and unmet assumptions affecting the valuation of intangible assets.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.